Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greg R Pond

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
European Urology|December 31, 2010
Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experienceJeremy F Sturgeon, Malcolm J Moore, David M Kakiashvili, et al.
JAMA Oncology|February 4, 2021
Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical TrialLaurence Klotz, Joseph Chin, Peter C Black, et al.
NPJ Breast Cancer|July 9, 2021
Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology studyJohn M S Bartlett, Jane Bayani, Elizabeth Kornaga, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
European Urology|December 31, 2010
Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experienceJeremy F Sturgeon, Malcolm J Moore, David M Kakiashvili, et al.
JAMA Oncology|February 4, 2021
Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical TrialLaurence Klotz, Joseph Chin, Peter C Black, et al.
NPJ Breast Cancer|July 9, 2021
Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology studyJohn M S Bartlett, Jane Bayani, Elizabeth Kornaga, et al.
Pageof 2